Evidence map›Paper›PMID 37651473›Full record

SynthesisPLoS neglected tropical diseases2023

Secondary vectors of Zika Virus, a systematic review of laboratory vector competence studies.

Marina Bisia, Carlos Alberto Montenegro-Quinoñez, Peter Dambach, Andreas Deckert, Olaf Horstick, Antonios Kolimenakis, Valérie R Louis, Pablo Manrique-Saide, Antonios Michaelakis, Silvia Runge-Ranzinger and 1 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Marina BisiaLaboratory of Insects and Parasites of Medical Importance, Scientific Directorate of Entomology and Agricultural Zoology, Benaki Phytopathological Institute, Athens, Greece.
Carlos Alberto Montenegro-QuinoñezHeidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Peter DambachHeidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Andreas DeckertHeidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Olaf HorstickHeidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Antonios KolimenakisLaboratory of Insects and Parasites of Medical Importance, Scientific Directorate of Entomology and Agricultural Zoology, Benaki Phytopathological Institute, Athens, Greece.
Valérie R LouisHeidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Pablo Manrique-SaideUnidad Colaborativa para Bioensayos Entomológicos (UCBE), Universidad Autónoma de Yucatán, Mérida, México.
Antonios MichaelakisLaboratory of Insects and Parasites of Medical Importance, Scientific Directorate of Entomology and Agricultural Zoology, Benaki Phytopathological Institute, Athens, Greece.
Silvia Runge-RanzingerHeidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Amy C MorrisonDepartment of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, United States of America.ORCID 0000-0001-6224-5984
Heidelberg University · DEBenaki Phytopathological Institute · GRAutonomous University of Yucatán · MXUniversidad de San Carlos de Guatemala · GTUniversity of California, Davis · US

Funding

SARS-CoV-2 genomic variant surveillance in human and non-human primate populations in PeruU01AI151814 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BARKER, CHRISTOPHER M, COFFEY, LARK L · 2020 to 2024
$8.9M
NIAID NIH HHS U01 AI151814
6 · The paper itself

Abstract

backgroundAfter the unprecedented Zika virus (ZIKV) outbreak in the western hemisphere from 2015-2018, Aedes aegypti and Ae. albopictus are now well established primary and secondary ZIKV vectors, respectively. Consensus about identification and importance of other secondary ZIKV vectors remain. This systematic review aims to provide a list of vector species capable of transmitting ZIKV by reviewing evidence from laboratory vector competence (VC) studies and to identify key knowledge gaps and issues within the ZIKV VC literature.

methodsA search was performed until 15th March 2022 on the Cochrane Library, Lilacs, PubMed, Web of Science, WHOLIS and Google Scholar. The search strings included three general categories: 1) "ZIKA"; 2) "vector"; 3) "competence", "transmission", "isolation", or "feeding behavior" and their combinations. Inclusion and exclusion criteria has been predefined and quality of included articles was assessed by STROBE and STROME-ID criteria.

findingsFrom 8,986 articles retrieved, 2,349 non-duplicates were screened by title and abstracts,103 evaluated using the full text, and 45 included in this analysis. Main findings are 1) secondary vectors of interest include Ae. japonicus, Ae. detritus, and Ae. vexans at higher temperature 2) Culex quinquefasciatus was not found to be a competent vector of ZIKV, 3) considerable heterogeneity in VC, depending on the local mosquito strain and virus used in testing was observed. Critical issues or gaps identified included 1) inconsistent definitions of VC parameters across the literature; 2) equivalency of using different mosquito body parts to evaluate VC parameters for infection (mosquito bodies versus midguts), dissemination (heads, legs or wings versus salivary glands), and transmission (detection or virus amplification in saliva, FTA cards, transmission to neonatal mice); 3) articles that fail to use infectious virus assays to confirm the presence of live virus; 4) need for more studies using murine models with immunocompromised mice to infect mosquitoes.

conclusionRecent, large collaborative multi-country projects to conduct large scale evaluations of specific mosquito species represent the most appropriate approach to establish VC of mosquito species.

Indexed as

AedesZika VirusZika Virus InfectionAnimalsBiological AssayMiceMosquito Vectors

Identifiers

PMID37651473
PMCPMC10499269
OpenAlexW4386317024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.